BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Business > article

Samsung Biologics scores victory in patent suit against Lonza of Switzerland

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : October 14, 2019, 15:01 | Updated : October 14, 2019, 15:01
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Samsung BioLogics]

SEOUL -- Samsung BioLogics, a leading bio company in South Korea, has scored a meaningful legal victory against Lonza, a Swiss chemicals and biotechnology company, to nullify patents involving cell line development technology

With the Korean Intellectual Property Tribunal's ruling, Samsung BioLogics said it can expand its contract development organization (CDO) business portfolio. CDO is a business that develops cell lines and production processes for the mass production of antibody-drug candidate substances developed at the laboratory level.

The cell line refers to cells that multiply massively to make desired antibody drugs. The patent is for some proteins that help cell line proliferation. The tribunal has ruled that Lonza's patent is not new as it is identical to the previously known technology and it can be easily invented by an ordinary engineer. Lonza can appeal the decision.

Samsung BioLogics filed for patent nullification in July 2017 on DNA vectors, which transfer genes for the production of antibodies into cell lines. In molecular cloning, a vector is a DNA molecule used as a vehicle to artificially carry foreign genetic material into another cell, where it can be replicated or expressed.

Samsung BioLogics has sought patent nullification, saying Lonza's patent was acting as an unfair entry barrier as it expanded its biomedicine business from contract manufacturing organization (CMO) to CDO. Samsung Biologics has signed 34 CDO contracts with clients.

CMO serves other companies in the pharmaceutical industry to provide comprehensive services from development through manufacturing. Lonza is a leading contract development and manufacturing organization (CDMO) that concurrently conducts CDO and CMO.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Celltrion forges partnership with Swiss pharmaceutical manufacturer to produce Remsima drug substance.
    Celltrion forges partnership with Swiss pharmaceutical manuf…
  • .Samsung Bioepis wins U.S. approval to sell biosimilar referencing Enbrel .
    Samsung Bioepis wins U.S. approval to sell biosimilar refere…
  • .Samsung BioLogics wins deal to produce CytoDyns drug candidate leronlimab.
    Samsung BioLogics wins deal to produce CytoDyn's drug candid…
  • .Samsung Bioepis forges licensing deal with Chinese private equity firm .
    Samsung Bioepis forges licensing deal with Chinese private e…
  • .Samsung Bioepis wins U.S. approval to sell cancer-treating biosimilar .
    Samsung Bioepis wins U.S. approval to sell cancer-treating b…

Real Time Photo News

  • .[FOCUS] Transparency in compiling music charts becomes hot topic in music community.

    [FOCUS] Transparency in compiling music charts becomes hot topic in music community

  • .Actor Park Seo-joon expresses sadness over hacked YouTube channel.

    Actor Park Seo-joon expresses sadness over hacked YouTube channel

  • .Big Hit refutes JTBCs news report about BTS seeking legal help over profit distribution.

    Big Hit refutes JTBC's news report about BTS seeking legal help over profit distribution

  • .​[PHOTO] President Moon meets rock band U2s Bono.

    ​[PHOTO] President Moon meets rock band U2's Bono

  • .​JYP Entertainment to take necessary actions to protect TWICE members against stalker.

    ​JYP Entertainment to take necessary actions to protect TWICE members against stalker

Latest News

more+

  • Daewoo shipyard works on design upgrade of submarine pressure hull
  • KB Investment creates joint investment fund with Indonesia's Telkom
  • Girl band MAMAOO launches new type of virtual reality concert album to mesmerize fans
  • [FOCUS] Transparency in compiling music charts becomes hot topic in music community
  • Actor Park Seo-joon expresses sadness over hacked YouTube channel
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view